Search results
Results From The WOW.Com Content Network
By Leroy Leo and Michael Erman. (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Merck's treatment for adults with high blood pressure due to constriction of lung arteries ...
Ridaforolimus (also known as AP23573 and MK-8669; formerly known as deforolimus) is an investigational targeted and small-molecule inhibitor of the protein mTOR, a protein that acts as a central regulator of protein synthesis, cell proliferation, cell cycle progression and cell survival, integrating signals from proteins, such as PI3K, AKT and PTEN known to be important to malignancy.
Cathay Drug is recognized as one of the fastest-growing pharmaceutical companies in the Philippines. In 2012, it was included in the Top 20 Leading Philippine Pharmaceutical Companies based on Value in the Philippine Pharmaceutical Industry Audit [3] for ethical segment by IMS. It was also ranked second among national pharmaceutical companies ...
June 11, 2024 at 12:19 PM. By Mariam Sunny and Sneha S K. (Reuters) -Merck is focused on second- and third-generation opportunities in the cardiometabolic drugs market, which includes weight-loss ...
Merck Serono (EMD Serono in the United States and Canada) is a pharmaceutical company headquartered in Darmstadt, Germany, and a brand and division of Merck focused on biopharmaceuticals. [1] In September 2006, Merck KGaA announced its intent to purchase the majority of Serono shares from Ernesto Bertarelli and the Bertarelli family.
October 16, 2023 at 8:10 PM. (Reuters) -The U.S. Food and Drug Administration on Monday approved the expanded use of Merck & Co's blockbuster immunotherapy Keytruda in early-stage patients with ...
Acceleron Pharma, Inc. Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as ...
US FDA approves Merck's pneumococcal vaccine for adults. June 17, 2024 at 5:52 PM. (Reuters) -Merck said on Monday the U.S. Food and Drug Administration has approved its next-generation vaccine to ...